drugset / Trial / NCT05792111
Caudal Epidural Steroid and Trigger Point Injection
RandomizedParallel-groupSingle-blindTreatment
Summary
This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90
Timeline
- Start
- 2022-10-12
- Primary completion
- 2023-12-20
- Completion
- 2024-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | — | Intramuscular |
| Background | Bupivacaine | Other / unclassified | 20 mg | Other |
| Background | Triamcinolone | Other / unclassified | 80 mg | Other |